CEA as a blood-based biomarker in anal cancer

CONCLUSIONS: Despite interesting patterns of abnormally high CEA in SCCA patients with advanced disease, and correlation of increased CEA with disease progression (and conversely decreased CEA with disease response), CEA is not associated with survival outcomes in SCCA, and is not a clinically relevant biomarker in this disease.PMID:34084278 | PMC:PMC8169063 | DOI:10.18632/oncotarget.27959
Source: Oncotarget - Category: Cancer & Oncology Authors: Source Type: research